Latest Trials


EudraCT Number: 2008-005168-15 Sponsor Protocol Number: CQAV680A2201 Start Date:
Sponsor Name: Novartis Pharma Services AG
Full Title: A randomized, double-blind, two way cross-over, proof of concept study to compare the efficacy, safety, pharmacokinetics and pharmacodynamics of two-week oral administration of QAV680 versus placeb...
Medical condition: Mild to moderate persistent asthma, steroid-free patients
Disease: Version SOC Term Classification Code Term Level
9.1 10003553 Asthma LLT
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
3
Subscribe